Cargando…
Detection of the sentinel lymph node with hybrid tracer (ICG-[(99m)Tc]Tc-albumin nanocolloid) in intermediate- and high-risk endometrial cancer: a feasibility study
PURPOSE: Indocyanine green (ICG) is frequently used for the detection of the sentinel lymph node (SLN) in gynecology, but it carries the loss of the presurgical SLN mapping provided by [(99m)Tc]-based colloids. Hybrid tracers such as ICG-[(99m)Tc]Tc-albumin nanocolloid combine the benefits of both c...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671586/ https://www.ncbi.nlm.nih.gov/pubmed/34905122 http://dx.doi.org/10.1186/s13550-021-00863-x |
_version_ | 1784615168222691328 |
---|---|
author | Sánchez-Izquierdo, Nuria Vidal-Sicart, Sergi Campos, Francisco Torné, Aureli Angeles, Martina Aida Migliorelli, Federico Munmany, Meritxell Saco, Adela Diaz-Feijoo, Berta Glickman, Ariel Ordi, Jaume Perissinotti, Andrés del Pino, Marta Paredes, Pilar |
author_facet | Sánchez-Izquierdo, Nuria Vidal-Sicart, Sergi Campos, Francisco Torné, Aureli Angeles, Martina Aida Migliorelli, Federico Munmany, Meritxell Saco, Adela Diaz-Feijoo, Berta Glickman, Ariel Ordi, Jaume Perissinotti, Andrés del Pino, Marta Paredes, Pilar |
author_sort | Sánchez-Izquierdo, Nuria |
collection | PubMed |
description | PURPOSE: Indocyanine green (ICG) is frequently used for the detection of the sentinel lymph node (SLN) in gynecology, but it carries the loss of the presurgical SLN mapping provided by [(99m)Tc]-based colloids. Hybrid tracers such as ICG-[(99m)Tc]Tc-albumin nanocolloid combine the benefits of both components. The aim of this study was to evaluate the feasibility and applicability of this hybrid tracer injected by transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR) approach in the detection of SLNs in patients with intermediate- and high-risk EC. METHODS: Fifty-two patients with intermediate- and high-risk EC underwent SLN biopsy after injection of a hybrid tracer using the TUMIR approach, followed by pelvic and paraaortic lymphadenectomy. SLNs were detected preoperatively by lymphoscintigraphic study and intraoperatively by gamma probe and near-infrared (NIR) optical laparoscopic camera. RESULTS: Preoperative lymphatic drainage was obtained in 69% and intraoperative detection in 71.4% of patients. A total of 146 SLNs (4.17 SLNs/patient) were biopsied. Pelvic bilateral detection was observed in 57% of the women and paraaortic drainage in 34% of the patients. The radioactive component allowed the detection of SLN in 97.1% of the patients, while the fluorescent component detected 80%. In more than 17% of the patients with intraoperative detection, SLNs were detected only by the radioactive signal. Lymph node metastasis was identified in 14.3% of patients submitted to SLNB. The sensitivity and negative predictive value for metastatic involvement were 100%. CONCLUSION: TUMIR injection of a hybrid tracer in patients with intermediate- and high-risk EC combines the benefits of the radiotracer and the fluorescence methods with a single tracer. The method increases the paraaortic detection rate and allows a potential increase in SLN detection. Notwithstanding, based on our findings, the radioactive component of the hybrid tracer cannot be obviated. |
format | Online Article Text |
id | pubmed-8671586 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-86715862021-12-17 Detection of the sentinel lymph node with hybrid tracer (ICG-[(99m)Tc]Tc-albumin nanocolloid) in intermediate- and high-risk endometrial cancer: a feasibility study Sánchez-Izquierdo, Nuria Vidal-Sicart, Sergi Campos, Francisco Torné, Aureli Angeles, Martina Aida Migliorelli, Federico Munmany, Meritxell Saco, Adela Diaz-Feijoo, Berta Glickman, Ariel Ordi, Jaume Perissinotti, Andrés del Pino, Marta Paredes, Pilar EJNMMI Res Original Research PURPOSE: Indocyanine green (ICG) is frequently used for the detection of the sentinel lymph node (SLN) in gynecology, but it carries the loss of the presurgical SLN mapping provided by [(99m)Tc]-based colloids. Hybrid tracers such as ICG-[(99m)Tc]Tc-albumin nanocolloid combine the benefits of both components. The aim of this study was to evaluate the feasibility and applicability of this hybrid tracer injected by transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR) approach in the detection of SLNs in patients with intermediate- and high-risk EC. METHODS: Fifty-two patients with intermediate- and high-risk EC underwent SLN biopsy after injection of a hybrid tracer using the TUMIR approach, followed by pelvic and paraaortic lymphadenectomy. SLNs were detected preoperatively by lymphoscintigraphic study and intraoperatively by gamma probe and near-infrared (NIR) optical laparoscopic camera. RESULTS: Preoperative lymphatic drainage was obtained in 69% and intraoperative detection in 71.4% of patients. A total of 146 SLNs (4.17 SLNs/patient) were biopsied. Pelvic bilateral detection was observed in 57% of the women and paraaortic drainage in 34% of the patients. The radioactive component allowed the detection of SLN in 97.1% of the patients, while the fluorescent component detected 80%. In more than 17% of the patients with intraoperative detection, SLNs were detected only by the radioactive signal. Lymph node metastasis was identified in 14.3% of patients submitted to SLNB. The sensitivity and negative predictive value for metastatic involvement were 100%. CONCLUSION: TUMIR injection of a hybrid tracer in patients with intermediate- and high-risk EC combines the benefits of the radiotracer and the fluorescence methods with a single tracer. The method increases the paraaortic detection rate and allows a potential increase in SLN detection. Notwithstanding, based on our findings, the radioactive component of the hybrid tracer cannot be obviated. Springer Berlin Heidelberg 2021-12-14 /pmc/articles/PMC8671586/ /pubmed/34905122 http://dx.doi.org/10.1186/s13550-021-00863-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Research Sánchez-Izquierdo, Nuria Vidal-Sicart, Sergi Campos, Francisco Torné, Aureli Angeles, Martina Aida Migliorelli, Federico Munmany, Meritxell Saco, Adela Diaz-Feijoo, Berta Glickman, Ariel Ordi, Jaume Perissinotti, Andrés del Pino, Marta Paredes, Pilar Detection of the sentinel lymph node with hybrid tracer (ICG-[(99m)Tc]Tc-albumin nanocolloid) in intermediate- and high-risk endometrial cancer: a feasibility study |
title | Detection of the sentinel lymph node with hybrid tracer (ICG-[(99m)Tc]Tc-albumin nanocolloid) in intermediate- and high-risk endometrial cancer: a feasibility study |
title_full | Detection of the sentinel lymph node with hybrid tracer (ICG-[(99m)Tc]Tc-albumin nanocolloid) in intermediate- and high-risk endometrial cancer: a feasibility study |
title_fullStr | Detection of the sentinel lymph node with hybrid tracer (ICG-[(99m)Tc]Tc-albumin nanocolloid) in intermediate- and high-risk endometrial cancer: a feasibility study |
title_full_unstemmed | Detection of the sentinel lymph node with hybrid tracer (ICG-[(99m)Tc]Tc-albumin nanocolloid) in intermediate- and high-risk endometrial cancer: a feasibility study |
title_short | Detection of the sentinel lymph node with hybrid tracer (ICG-[(99m)Tc]Tc-albumin nanocolloid) in intermediate- and high-risk endometrial cancer: a feasibility study |
title_sort | detection of the sentinel lymph node with hybrid tracer (icg-[(99m)tc]tc-albumin nanocolloid) in intermediate- and high-risk endometrial cancer: a feasibility study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671586/ https://www.ncbi.nlm.nih.gov/pubmed/34905122 http://dx.doi.org/10.1186/s13550-021-00863-x |
work_keys_str_mv | AT sanchezizquierdonuria detectionofthesentinellymphnodewithhybridtracericg99mtctcalbuminnanocolloidinintermediateandhighriskendometrialcancerafeasibilitystudy AT vidalsicartsergi detectionofthesentinellymphnodewithhybridtracericg99mtctcalbuminnanocolloidinintermediateandhighriskendometrialcancerafeasibilitystudy AT camposfrancisco detectionofthesentinellymphnodewithhybridtracericg99mtctcalbuminnanocolloidinintermediateandhighriskendometrialcancerafeasibilitystudy AT torneaureli detectionofthesentinellymphnodewithhybridtracericg99mtctcalbuminnanocolloidinintermediateandhighriskendometrialcancerafeasibilitystudy AT angelesmartinaaida detectionofthesentinellymphnodewithhybridtracericg99mtctcalbuminnanocolloidinintermediateandhighriskendometrialcancerafeasibilitystudy AT migliorellifederico detectionofthesentinellymphnodewithhybridtracericg99mtctcalbuminnanocolloidinintermediateandhighriskendometrialcancerafeasibilitystudy AT munmanymeritxell detectionofthesentinellymphnodewithhybridtracericg99mtctcalbuminnanocolloidinintermediateandhighriskendometrialcancerafeasibilitystudy AT sacoadela detectionofthesentinellymphnodewithhybridtracericg99mtctcalbuminnanocolloidinintermediateandhighriskendometrialcancerafeasibilitystudy AT diazfeijooberta detectionofthesentinellymphnodewithhybridtracericg99mtctcalbuminnanocolloidinintermediateandhighriskendometrialcancerafeasibilitystudy AT glickmanariel detectionofthesentinellymphnodewithhybridtracericg99mtctcalbuminnanocolloidinintermediateandhighriskendometrialcancerafeasibilitystudy AT ordijaume detectionofthesentinellymphnodewithhybridtracericg99mtctcalbuminnanocolloidinintermediateandhighriskendometrialcancerafeasibilitystudy AT perissinottiandres detectionofthesentinellymphnodewithhybridtracericg99mtctcalbuminnanocolloidinintermediateandhighriskendometrialcancerafeasibilitystudy AT delpinomarta detectionofthesentinellymphnodewithhybridtracericg99mtctcalbuminnanocolloidinintermediateandhighriskendometrialcancerafeasibilitystudy AT paredespilar detectionofthesentinellymphnodewithhybridtracericg99mtctcalbuminnanocolloidinintermediateandhighriskendometrialcancerafeasibilitystudy |